In conclusion, considering the previous evidence on the antiapoptotic activity of BIRC6 and the effects of silencing BIRC6 expression in breast and lung cancer cells on in vitro and in vivo experimental models, we propose that baculovirus-mediated BIRC6 silencing holds strong potential as an alternative therapeutic strategy. The gene discussed is BIRC6; the disease is lung cancer.